In addition to quieting that food noise, these types of weight loss medications can actually reduce heart disease, that might be independent of weight loss, in addition to improvements in heart function and functional status in individuals with heart failure. The medication is also currently being studied for how it can target symptoms of kidney disease and Alzheimers
But the results we have so far are impressive (more on that below!)
Clinicians should emphasize overall health improvements rather than focusing solely on weight changes
doi: 10.3389/fendo.2021.721198 23 CalsolaroVEdisonP
Unlike injectable GLP-1 medications such as Zepbound (tirzepatide) or Wegovy (semaglutide), Foundayo is a small-molecule, non-peptide drug
Efficacy and Safety of the Once-Daily Human GLP-1 Analogue, Liraglutide, vs Glibenclamide Monotherapy in Japanese Patients With Type 2 Diabetes